About
Juliet Gray is a Professor of Paediatric Oncology, working in the Department of Paediatric Oncology at Southampton Children's Hospital and the Centre for Cancer Immunology at the University of Southampton. Her main clinical and research interest is in neuroblastoma and cancer immunotherapy. She leads a translational research group focused on the development of novel antibody therapies, and also leads a number of international clinical trials for children with neuroblastoma.
Research
Research groups
Member of:
Research interests
- Fc modification of monoclonal antibodies to improve effector function
Research projects
Active projects
Researchers:
Sponsor: Childrens Cancer and Leukaemia Group
Sponsor: Childrens Cancer and Leukaemia Group
Researchers:
Sponsor: Cancer Research UK
Researchers:
Completed projects
Researchers:
Sponsor: Wessex Medical Research
Researchers:
Sponsor: Sparks Children's Medical Research Charity
Researchers:
Researchers:
Sponsor: Cancer Research UK
Researchers:
Sponsor: Wessex Cancer Trust
Sponsor: Childrens Cancer and Leukaemia Group
Researchers:
Researchers:
Researchers:
Researchers:
Sponsor: Cancer Research UK
Researchers:
Sponsor: Childrens Cancer and Leukaemia Group
Researchers:
Sponsor: Neuroblastoma UK
Researchers:
Sponsor: Cancer Research UK
Researchers:
Sponsor: Cancer Research UK
Researchers:
Sponsor: Children with Cancer UK
Researchers:
Sponsor: Wessex Medical Research
Researchers:
Sponsor: Neuroblastoma UK
Researchers:
Sponsor: Childrens Cancer and Leukaemia Group
Publications
49 publications
Page 5 of 5
Emily L. Williams, Stuart N. Dunn, Sonya James, Peter W. Johnson, Mark S. Cragg, Martin J. Glennie & Juliet C. Gray,
2013, Clinical Cancer Research, 19(13), 3545-3555
Type: article
Claudine Sinsioco, Kenneth Silver, Katharine M. Forrest, Juliet Gray, Alla Nechay, Stephen Sheldon & Ewa Chelmicka Schorr,
2013, Pediatric Neurology, 49(1), 64-67
Type: article
Elizabeth A. Calton, I. Karen Temple, Deborah J.G. Mackay, Margaret Lever, Sian Ellard, Sarah E. Flanagan, Justin H. Davies, Khalid Hussain & Juliet C. Gray,
2013, European Journal of Medical Genetics, 56(2), 114-117
Type: article
Jane Carr-Wilkinson, Luke Wylie, John Anderson & Juliet Gray,
2012, Pediatric Blood and Cancer, 59(3), 594-596
DOI: 10.1002/pbc.24230
Type: article
Elizabeth A Calton, S.N. Faust & Juliet C. Gray,
2011, Vaccines in Practice, 4(3), 4-7
Type: article
Juliet C. Gray & Janice A. Kohler,
2009, Pediatric Blood and Cancer, 53(6), 931-940
DOI: 10.1002/pbc.22153
Type: article
Juliet C. Gray, Ruth R. French, Sonya James, Aymen Al-Shamkhani, Peter W. Johnson & Martin J. Glennie,
2008, European Journal of Immunology, 38(9), 2499-2511
Type: article
Ruth R. French, Vadim Y. Taraban, Graham R. Crowther, Tania F. Rowley, Juliet C. Gray, Peter W. Johnson, Alison L. Tutt, Aymen Al-Shamkhani & Martin J. Glennie,
2007, Blood, 109(11), 4810-4815
Type: article
J.C. Gray, P.W.M. Johnson & M.J. Glennie,
2006, Clinical Science, 111(2), 93-106
Type: article
External roles and responsibilities
Name:
Member of Scientific Advisory Board, Solving Kids Cancer (External organisation)
Role:
Member
Year:
2017 -
Name:
Member of Executive Commitee European Neuroblastom Reseach Network (SIOPEN) (External organisation)
Role:
Member
Year:
2015 - 2019
Name:
Member of NCRI Childhood Cancer Leukaemia Clinical Study Group (External organisation)
Role:
Member
Year:
2017 -
Name:
Member of CRUK Protocol Safety Review Board (External organisation)
Role:
Member
Year:
2016 -
Name:
Invited expert to NICE Single Technology Appraisal Committee (Anti-GD2 in neuroblastoma) (External organisation)
Role:
Member
Year:
2016 - 2018
Name:
Chair of NCRI CG Neuroblastoma subgroup (External organisation)
Role:
Chair
Year:
2018 -
Name:
Member of national paediatric Experimental Cancer Medicine Centre Steering Group (External organisation)
Role:
Member
Year:
2017 -
Name:
SIOPEN European Neuroblastoma Research Network, Chair of Clinical Trials Committee (External organisation)
Role:
Chair
Year:
2020 -
Name:
Irish Cancer Society (External organisation)
Role:
Member
Year:
2020
Name:
Neuroblastoma Australia - member of Scientific Advisory Board (External organisation)
Role:
Chair
Year:
2019 -
Biography
- Early phase immunotherapy trials for neuroblastoma
Prizes
- ‘Outstanding Principal Investigator’ CRN Wessex Awards 2018: (2018)
- Solving Kids Cancer Research Hero (2022)